Butyric Acid Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Butyric Acid Market Trends and Insights

Growing Utilization in Animal-Feed Gut-Health Additives

Regulatory bans on growth-promoting antibiotics in Europe and voluntary phase-outs in North America have accelerated the switch to sodium butyrate and tributyrin, which improve intestinal barrier function and microbiome balance, translating into 5%–8% stronger feed conversion ratios. Precision-feeding platforms dose protected butyrate in real time, lifting per-animal consumption by up to 15% over static rations. Kemin Industries disclosed a 22% year-over-year rise in protected butyrate sales into Asian aquaculture during 2025 as shrimp farmers sought antibiotic-free mortality control^{[1]Kemin Industries, “Technical Bulletin: Protected Butyrate in Shrimp Health,” kemin.com}. China’s Ministry of Agriculture streamlined additive registrations in 2025, triggering local fermentation capacity additions due online in 2027.

Demand as Natural Flavoring & Clean-Label Preservative

Food manufacturers in the United States and European Union continue to replace synthetic diacetyl with butyric acid esters to satisfy transparent-label expectations. The US Food and Drug Administration reaffirmed the compound’s GRAS status for flavoring in 2024, and the European Food Safety Authority removed concentration caps on butyrate esters for dairy applications in 2025^{[2]European Food Safety Authority, “Re-evaluation of Butyrate Esters for Use in Dairy Applications,” efsa.europa.eu}. Formulators report being able to cut potassium sorbate loadings by 30% when leveraging butyric acid’s mild antimicrobial action, reducing both cost and label length. Clean-label positioning propelled a 12% jump in North American and European food-grade demand during 2025.

Pharma Interest in SCFA-Based Therapeutics & Pro-Drugs

Phase II clinical data published in 2025 showed enteric-coated sodium butyrate tablets lowering ulcerative colitis activity scores by 40% against placebo, stimulating investigational new drug applications for butyrate-centered therapies. Pro-drug versions such as tributyrin enhance systemic bioavailability by bypassing rapid hepatic metabolism, while high-purity feedstock must meet stringent USP or Ph.Eur. heavy-metal and solvent specifications. Merck KGaA’s launch of ≥99.5%-pure butyric acid in 2024 underscores confidence in impending regulatory approvals.

Adoption of Precision-Livestock Farming Enabling Butyrate-Based Productivity Tools

Sensor-equipped feeding lines and wearable gut-health trackers let producers titrate butyrate inclusion in response to live inflammatory markers, trimming overuse during low-stress periods and intensifying supplementation during weaning or heat stress. A 2025 journal study found that dynamic dosing reduced feed cost per kilogram of broiler weight gain by 8% compared to fixed protocols. Swine nurseries recorded three-point mortality reductions when applying targeted butyrate delivery in the first 10 days post-weaning. Asia-Pacific integrators increasingly employ blockchain tracing to certify antibiotic-free meat, commanding 15%–20% export premiums in Japan and South Korea.

Volatile Butanol & Propylene Feedstock Prices

Petrochemical routes tie production costs to butanol and propylene spot prices, which swung 25% in early 2025 amid US Gulf Coast and Middle East refinery outages, squeezing margins for producers lacking long-term contracts. Chinese electrolytic pathways starting from maleic anhydride also experienced a 12% cost hike after domestic butane shortages. While fermentation insulation exists, current separation costs keep renewable butyric acid near the upper end of competitive price bands outlined in a 2025 techno-economic study.

Odor-Control & Handling Challenges Limiting Plant Adoption

The compound’s rancid-butter odor is detectable at parts-per-billion, necessitating sealed reactors, vapor scrubbers, and specialized storage, adding 20%–30% to greenfield capital outlays. A proposed 15,000-tonne German plant required a EUR 4 million odor-abatement upgrade before permitting approval in 2024. Downstream additive suppliers rely on lipid microencapsulation to mask odor, adding USD 0.80–1.20 per kilogram to finished product cost. Tokyo Chemical Industry’s SDS lists the flash point at 75°C and a corrosive classification, underlining stringent handling needs.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Source: Renewable Routes Gain Traction Amid Sustainability Mandates

Synthetic pathways controlled 62.24% of total volume in 2025, reflecting mature propylene-oxidation infrastructure. Nevertheless, renewable butyric acid is rising at an 8.92% CAGR as carbon pricing and circular-bioeconomy targets push brands to decouple from fossil feedstocks. The butyric acid market size for renewable supply is projected to expand from 22.2 kilotons in 2026 to 36.3 kilotons by 2031, equating to 44% of incremental demand. Fermentation titers exceeding 70 g/L have been demonstrated, yet downstream separation still represents around 60% of total cost. The butyric acid market share for synthetic feedstock could slip below 55% by 2031 if European carbon tariffs and Chinese subsidy programs materialize as scheduled.

Renewable developers are forging partnerships with municipal waste processors, exemplified by Perstorp’s Swedish demonstration plant that ferments sorted food waste to pharmaceutical-grade butyric acid. China’s Ministry of Industry and Information Technology embedded butyric acid in its 2024–2027 Fine Chemical Innovation Plan, offering tax rebates and pilot funding for non-food biomass routes. Synthetic producers retain an edge on cost and scale for industrial-grade sales, but brand owners in food and pharma now pay premiums of 15%–25% for verified renewable material.

By Grade: Pharmaceutical Purity Commands Premium as Therapeutic Pipelines Advance

Food-grade butyric acid accounted for 40.67% of 2025 demand, supplying butter-flavor esters and clean-label preservatives. Pharmaceutical-grade volumes remain smaller but carry gross margins roughly double those of food-grade. The butyric acid market size for pharmaceutical applications is forecast to climb from 5.9 kilotons in 2026 to 9.7 kilotons in 2031, reflecting a 9.10% CAGR. Clinical trials have moved into Phase III for ulcerative colitis, and drug sponsors require more than or equal to 99.5% purity and sub-ppm heavy-metal limits. Merck and Tokyo Chemical Industry expanded chromatography capacity during 2024–2025 to service this exacting niche.

Industrial-grade users, particularly cellulose butyrate and plasticizer manufacturers, value price over purity, purchasing products that permit higher aldehyde content. Regulatory tailwinds may eventually raise baseline purity thresholds even for industrial buyers, narrowing the cost gap but benefiting players with existing high-purity infrastructure. Food-grade remains the largest slice of the butyric acid market, but pharmaceuticals deliver the strongest profit uplift per unit of installed capacity.

By Application: Animal Feed Leads Volume and Growth as Antibiotic Alternatives Gain Traction

Animal feed held 38.41% of 2025 consumption and is expanding at a 9.61% CAGR, bolstered by antimicrobial resistance regulations and rising protein demand in Asia. The butyric acid market share for feed additives is projected to grow as precision-dosing platforms integrate real-time gut-health data, raising per-animal inclusion rates. Kemin Industries reported double-digit annual growth in protected butyrate adoption among Vietnamese and Thai shrimp farms, confirming cross-species applicability.

Chemical intermediates captured roughly one-quarter of volumes, but their cyclical link to downstream polymer demand tempers growth prospects. Food-flavor esters market share is underpinned by clean-label bakery and dairy reformulations in Europe following EFSA’s positive 2025 opinion.

Perfume applications remain mature and price sensitive. Biofuel pathways that convert butyric acid to 1-butanol or heavier hydrocarbons have cleared technical hurdles, yet remain niche until policy credit values widen.

Geography Analysis

Asia-Pacific retained 38.82% of worldwide demand in 2025 and is on track for an 8.14% CAGR through 2031. China accounts for almost half of global capacity, leveraging proximity to maleic anhydride and butanol feedstocks, while new fermentation projects aim to meet tightening sustainability targets. India’s poultry expansion, coupled with antibiotic-restriction policies, adds 1,200–1,500 tonnes per year of incremental butyrate demand. Japanese and South Korean pharmaceutical importers rely on high-purity products from Tokyo Chemical Industry and European partners. A gradual shift to renewable sourcing is expected as Chinese provinces implement carbon-trading schemes and Europe applies border adjustments.

US producers such as Eastman Chemical invest in high-chromatography purification to meet clinical-trial needs, leveraging the FDA’s reaffirmed GRAS status for flavoring applications. Europe’s circular-economy directives provide grants for waste-fed fermentation plants, epitomized by Perstorp’s Swedish demo unit. Precision-livestock platforms that modulate butyrate based on gut-health biomarkers expand rapidly in the U.S. broiler and swine sectors, supporting annual feed-grade growth. 

South America benefits from Brazil’s broiler export ambitions and Argentina’s recovery in animal husbandry investment. Producers test protected-butyrate feed additives to satisfy European importers’ antibiotic-free requirements. In the Middle East and Africa, Saudi Arabia and South Africa are scaling the dairy and poultry sectors. Infrastructure constraints and climate factors slow adoption relative to other regions, yet pharmaceutical imports continue to rise.

Value Chain Analysis

The butyric acid value chain starts with upstream feedstocks and utilities. Synthetic production economics are closely tied to petrochemical inputs such as propylene-derived intermediates and the butanol or butyraldehyde chains, which leaves producers exposed to feedstock volatility like the kind seen in early 2025. Renewable routes draw on sugars and biomass streams (for example, glucose, molasses, and lignocellulosic residues) fermented using strains such as Clostridium tyrobutyricum, but downstream separation remains a key cost and scale-up constraint, alongside odor-control hardware and permitting requirements.

Midstream, merchant producers (including Eastman Chemical Company, OXEA GmbH, Celanese Corporation, BASF, and Perstorp) supply food, industrial, and pharmaceutical grades through a mix of direct contracts and specialty chemical distribution, with large-volume buyers typically purchasing under multi-year agreements. Downstream demand concentrates in animal nutrition and formulation players that convert butyric acid into feed solutions (including protected or microencapsulated formats), and in flavor houses formulating butyrate esters for dairy and bakery notes. These customers prioritize traceability, consistent odor specification, and compliance (GMP and food-safety systems for food and pharma supply). Key bottlenecks include purification capacity for higher grades and logistics infrastructure designed for corrosive, odor-intensive materials, such as sealed handling, vapor management, and dedicated storage.

Market Opportunities and Future Outlook

Near-term whitespace is concentrated on de-risking supply and upgrading product formats for feed and regulated end uses, where buyers pay for consistency, documentation, and performance rather than commodity pricing. Large livestock and aquaculture integrators are substituting sub-therapeutic antibiotics with organic-acid solutions, which pulls demand toward protected-butyrate systems and tighter origin certification, particularly in Europe and in export-oriented Asia-Pacific production chains. In food and flavors, EFSA actions in 2025 that eased constraints on butyrate esters in dairy applications support reformulation activity that shifts demand toward consistent food-grade supply and ester-grade intermediates.

Renewable and circular sourcing also creates an opportunity for fermentation producers that can pair lower-carbon feedstocks with credible mass-balance and chain-of-custody documentation. Corporate activity such as Perstorp's Asia expansion (including its India facility inauguration in November 2024) and commercialization steps like the March 2025 METEX NOOVISTA and ALINOVA agreement for 100% bio-based butyric acid in animal nutrition in France point to market pull for differentiated, bio-based offerings. On the technology side, published techno-economic work that highlights material cost and emissions advantages when integrating first-generation and lignocellulosic feedstocks strengthens the business case for projects that combine higher fermentation productivity with improved separations, particularly for customers seeking measurable carbon reductions without changing away from existing butyrate-based formulations.